PCG vs PHAT · P/E 13, rev $24.93B vs rev $55.3M
PG&E Corp (PCG) versus Phathom Pharmaceuticals Inc (PHAT) — a side-by-side from cached financials, not a winner call.
PG&E Corp (PCG) is a utilities - regulated electric company listed on US.
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
Latest reported PCG revenue for 2025-12-31 was $24.93B. Net income was $2.6K. Revenue was up 2.1% from 2024-12-31 to 2025-12-31. PCG currently screens at market cap $37.68B and trailing P/E 13.3.
Latest reported PHAT revenue for 2024-12-31 was $55.3M. Net income was -$334.3M. Revenue was up 8001.5% from 2023-12-31 to 2024-12-31. PHAT currently screens at market cap $622.7M.
PCG currently screens at market cap $37.68B and trailing P/E 13.3. PHAT currently screens at market cap $622.7M.
Not investment advice. Open the PCG and PHAT stock pages for the full models.
Not investment advice.